taxifolin and Lung Injury, Acute

taxifolin has been researched along with Lung Injury, Acute in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Cao, L; Li, C; Liu, JH; Wu, Q; Zhang, CH; Zhang, ZH1
Cimen, FK; Kuzucu, M; Olmez, H; Suleyman, Z; Tosun, M; Unver, E1

Other Studies

2 other study(ies) available for taxifolin and Lung Injury, Acute

ArticleYear
Dihydroquercetin attenuates lipopolysaccharide-induced acute lung injury through modulating FOXO3-mediated NF-κB signaling via miR-132-3p.
    Pulmonary pharmacology & therapeutics, 2020, Volume: 64

    Topics: Acute Lung Injury; Forkhead Box Protein O3; Humans; Lipopolysaccharides; MicroRNAs; NF-kappa B; Quercetin

2020
The Effect of Taxifolin on Cisplatin-Induced Pulmonary Damage in Rats: A Biochemical and Histopathological Evaluation.
    Mediators of inflammation, 2019, Volume: 2019

    Topics: Acute Lung Injury; Animals; Antioxidants; Cisplatin; DNA Damage; Glutathione; Malondialdehyde; Oxidative Stress; Quercetin; Rats; Rats, Wistar

2019